HydraFacial to go public via $1.1 bln deal with former Allergan CEO-backed SPAC

Reuters
2020/12/09

Dec 9 (Reuters) - A blank-check acquisition firm cofounded by the former chief executive officer of Allergan, Brent Saunders, will merge with beauty company HydraFacial in a deal valued at $1.1 billion including debt, the companies said on Wednesday.

HydraFacial's merger with Saunder's Vesper Healthcare Acquisition Corp will result in the Long Beach, California-based company listing on the Nasdaq.

The deal consists of $975 million payable upon completion and $75 million after certain acquisitions are completed by the combined company.

This adds to a wave of recent deals by so-called SPACs or special purpose acquisition companies, shell vehicles that raise money in an initial public offering to buy and then merge with another company, typically within two years.

Vesper went public in November, just a few months after AbbVie Inc closed its blockbuster $63 billion deal for Allergan, securing access to the anti-wrinkle injection Botox.

HydraFacial's skin-cleansing products are available in over 87 countries. The company was acquired by private equity firms Linden and DWHP in 2016.

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

((Manas.Mishra@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10